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ABSTRACT
There is increasing evidence of crosstalk between
epigenetic modifications such as histone and
DNA methylation, recognized by HP1 and methyl
CpG-binding proteins, respectively. We have
previously shown that the level of methyl CpG-
binding proteins increased dramatically during
myogenesis leading to large-scale heterochromatin
reorganization. In this work, we show that the level
of HP1 isoforms did not change significantly
throughout myogenic differentiation but their loca-
lization did. In particular, HP1c relocalization to
heterochromatin correlated with MeCP2 presence.
Using co-immunoprecipitation assays, we found
that these heterochromatic factors interact in vivo
via the chromo shadow domain of HP1 and the first
55 amino acids of MeCP2. We propose that this
dynamic interaction of HP1 and MeCP2 increases
their concentration at heterochromatin linking
two major gene silencing pathways to stabilize
transcriptional repression during differentiation.
INTRODUCTION
Post-translational modiﬁcations of chromatin such as
histone and DNA methylation are recognized by epige-
netic regulators HP1 (heterochromatin protein 1) and
MeCP2 (methyl CpG-binding protein 2) respectively and
play an important role in transcriptional regulation. These
non-histone chromatin factors read the epigenetic marks
and translate them into inactive chromatin states.
MeCP2 is a member of a family of proteins, which
share a conserved methyl cytosine-binding domain (MBD)
that recognizes methylated CpG dinucleotides (1).
Moreover, MeCP2 contains a nuclear localization signal
[NLS; (2)] and a transcriptional repression domain
(TRD), which binds a corepressor complex containing
mSin3a and histone deacetylases [HDACs; (3)].
HP1 proteins are conserved from yeast to humans (4)
and recognize histone H3 trimethylated at the lysine
9 position [H3K9Me3; (5,6)]. In mammals, three isoforms
viz a, b, g have been identiﬁed (7,8). Functionally, three
domains have been deﬁned in HP1(s). The chromodomain
[CD; (9)]and the chromo shadow domain [CSD; (10)] are
highly conserved and are linked by the poorly conserved
hinge domain. The CD has been shown to be important
for binding methylated histones, while the CSD is
known to interact with several proteins (11) as well as
mediate homo (12) and heterodimerization of HP1
isoforms (13). The hinge domain interacts with DNA
(14) and RNA (15).
In mouse cells, both HP1 and MeCP2 accumulate
at pericentric regions of chromosomes organized into
chromocenters, which play an important role in epigenetic
gene regulation possibly by creating silencing compart-
ments within the nucleus. Recently, we have shown that
the level of MeCP2 as well as of MBD proteins starkly
increased during myogenic diﬀerentiation concomitant
with large-scale chromatin reorganization (16). To inves-
tigate a potential crosstalk between both epigenetic
regulators, we analyzed the amount and localization of
HP1 with respect to MBD proteins during cellular
diﬀerentiation. We found that although the level of HP1
proteins does not change dramatically, there is spatial
relocalization of HP1 (especially HP1g) during myogenesis
from a more diﬀused distribution to a focal enrichment at
pericentric heterochromatin. Furthermore, this redistribu-
tion to heterochromatin correlates with MeCP2 and
MBD1 protein presence. We also demonstrate that HP1
and MeCP2 interact physically with each other,
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formation of repressive subnuclear compartments
involved in epigenetic gene silencing.
MATERIALS AND METHODS
Expression plasmids
The following HP1 plasmids were used: GFP-tagged
full-length human HP1a/HP1b/HP1g (17); YFP-tagged
deletion mutants of human HP1a/HP1b/HP1g and
full-length human HP1a/HP1b tagged with DsRed2 (18).
To construct a DsRed2 fusion of HP1g, the BamHI–
HindIII fragment of GFP-HP1g containing HP1g was
subcloned into BglII–HindIII site of pDsRed2-C1
(Clontech). MeCP2 constructs used were GFP/YFP/
mRFP1-tagged full-length and deletion mutants of rat
MeCP2 (16). MeCP2Y.6 and MeCP2G.7 were constructed
by subcloning XhoI–HindIII and XhoI–PstI fragments
of MeCP2 from MeCP2Y into pEYFP-N1and
pEGFP-N1 (Clontech) cut with the same restriction
enzymes, respectively. pEGFP-N1 (Clontech) was used
as a control.
Cell cultureand transfection
Pmi28 mouse myoblast cells (MB) were cultured as
described in (19), transfected using Transfectin (Biorad)
and diﬀerentiated as described before (16). Diﬀerentiated
cultures include syncitial myotubes (MT) and unfused
myocytes (MC).
HEK293-EBNA human cells (Invitrogen) were main-
tained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum at 378C with
5% CO2.4  10
5 HEK293-EBNA cells plated onto
100mm diameter culture dishes were transfected using
PEI (poly-ethyleneimine 25kDa from Polysciences
1mg/ml in ddH2O, neutralized with HCl). For transfec-
tion 500ml of DMEM without serum, 12mg of DNA and
50ml of PEI were mixed well, incubated for 10min at
room temperature, vortexed and added to the cells
dropwise. The culture was incubated at 378C overnight,
next day cells were washed in PBS, pelleted and used
for co-immunoprecipitation assays.
Immunofluorescence analysis and microscopy
Proliferating and diﬀerentiated Pmi28 cultures were
ﬁxed in 3.7% formaldehyde/PBS and permeabilized with
0.5% TritonX-100/1XPBS and immunostained as
described in (20). Primary antibodies used were: mouse
monoclonal anti-HP1 isoform-speciﬁc antibodies
(Chemicon), rabbit polyclonal anti-MeCP2 (Upstate)
and anti-MBD1 (Santa Cruz) antibodies. Secondary
antibodies used were: anti-mouse IgG-Cy5, anti-rabbit
IgG-FITC (Jackson Immuno Research). Samples were
counterstained with DAPI and examined on a Zeiss
Axiovert 200 using 40  and 63  objectives. Images were
acquired with a PCO Sensicam QE cooled CCD camera
using Zeiss Axiovision V.3 software and processed with
Adobe Photoshop. To quantify the correlation between
HP1g localization at chromocenters and presence of
MeCP2 or MBD1, we analyzed 375 MB cells; 71 cells
with positive staining for MeCP2; 99 cells with positive
staining for MBD1; 125 cells transfected with MeCP2-
GFP and 345 MT nuclei from two independent experi-
ments done in triplicate. The mean and SDs were plotted
using Microsoft Excel software (Figure 2).
Immunoprecipitation and westernblot analysis
Diﬀerentiated and non-diﬀerentiated Pmi28 cells were
grown on p100 culture dishes, boiled in Laemmli sample
buﬀer and analyzed on western blots (Figure 1).
Immunoprecipitations (Figures 3 and 4) were done as
described before (21). The following primary antibodies
were used: rabbit polyclonal anti-lamin B [kind gift of
R.Bastos; (22)], rabbit polyclonal anti-H3K9Me3
(Upstate), rabbit polyclonal anti-MeCP2 (Upstate), chro-
matographically puriﬁed rabbit IgG (Organon Teknika),
mouse monoclonal anti-HP1a/HP1b/HP1g (Chemicon),
rabbit polyclonal anti-histone H3 (Upstate), mouse
monoclonal anti-GFP (Roche), GFP binder (23), anti-
mRFP1 rabbit polyclonal antiserum. Secondary anti-
bodies used were: anti-mouse IgG HRP (Amersham)
and anti-rabbit IgG HRP (Sigma). Immunoreactive
signals were visualized using an ECL plus Detection kit
(Amersham) and recorded using a luminescence imager
(Luminescent Image Analyzer LAS-1000, Fuji). To
compare the amounts of the diﬀerent proteins in
proliferating and diﬀerentiated myogenic cultures,
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Figure 1. Level of HP1 proteins during diﬀerentiation. (A) Schematic representation of myogenesis. (B) Western blot analysis of the level of HP1
isoforms and of HP1-binding site on chromatin (H3K9Me3) in MB versus MC/MT. Lamin B and histone H3 are taken as controls for equal nuclear
protein amounts and for total histone H3, respectively. (C) Quantitative analysis of western blots. Error bars indicate SDs.
Nucleic Acids Research, 2007, Vol. 35, No. 16 5403quantiﬁcation of the recorded signals was done with the
Image Gauge Ver.3.0 software (Fuji). Equal sized
boxes were made around the recorded signals and for
calculating the background. Integrated pixel intensity was
measured for each band and the respective back-
ground signal was subtracted. Signals were normalized
to the loading control (lamin B or histone H3) and the fold
diﬀerence between the normalized signals in diﬀeren-
tiated versus proliferating cultures was calculated. The
mean and SDs were calculated from three independent
experiments and plotted using Microsoft Excel software
(Figure 1).
RESULTS AND DISCUSSION
Level ofHP1 isoforms remains mostly constant
during myogenesis
During cellular diﬀerentiation progressive inactivation
of the genome occurs in parallel with the activation of
tissue-speciﬁc gene expression patterns (24). We have
shown that the level of methyl CpG-binding protein
Figure 2. Pericentric heterochromatin association of HP1g increases
during diﬀerentiation and correlates with the presence of MeCP2 and
MBD1 proteins. (A) Cells were stained with HP1g and MeCP2-speciﬁc
antibodies and DNA counterstained with DAPI, highlighting the
chromocenters. In the upper panels, overview images and below them
representative magniﬁed MB cells are shown, of which only the MeCP2
positive cell has HP1g accumulated at chromocenters. The lower panels
show an overview of a diﬀerentiated culture, with most nuclei having
HP1g at chromocenters. Scale bar: 20mm. (B) Percentage of cells with
HP1g at pericentric heterochromatin and correlation with MeCP2 and
MBD1 proteins. Error bars indicate SD.
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Figure 3. MeCP2 interacts with HP1 in vivo.( A) Schematic representa-
tion of the fusion proteins. Numbers represent amino acid coordinates.
(B and C) HEK293-EBNA cells were transfected with the plasmids
indicated and extracts prepared the next day. Immunoprecipitations
were done using either anti-GFP (B) or anti-mRFP (C) antibody. (D)
Extracts from MB and MT were subjected to immunoprecipitation
using the antibodies, as indicated. Input (I) and bound (B) fractions
were loaded in the percentages mentioned and analyzed by western
blotting using anti-HP1g (B, D) or anti-GFP (C).
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induced large-scale aggregation of pericentric heterochro-
matin (16). A second major pathway associated with
transcriptional silencing is mediated by HP1 binding of
histone H3K9Me3. We therefore investigated whether the
level of the diﬀerent HP1 isoforms varied during cellular
diﬀerentiation using a well-established in vitro culture
system for myogenesis (Figure 1A). Pmi28 mouse myo-
blasts (MB) were induced to diﬀerentiate by incubation in
horse-serum-containing medium. After three to four days,
cells fused to form post-mitotic multinucleated myotubes
(MT). These cultures still contained mononucleated
not fully diﬀerentiated cells termed myocytes (MC).
We quantiﬁed the level of HP1 in proliferating versus
diﬀerentiated cell extracts by western blot analysis and
normalized it to lamin B level as a loading control
for nuclear proteins. The level of HP1a, b, g remained
almost constant during diﬀerentiation (Figure 1B and C).
However, the fraction of histone H3 that was
trimethylated at lysine 9 position (H3K9Me3) increased
about 3-fold in diﬀerentiated cells.
Association ofHP1cwithheterochromatin increases
during differentiation andcorrelates with methyl
CpG-binding proteinpresence
Previous studies have reported a cell cycle stage and
isoform-speciﬁc localization of HP1 (18). To address
this possibility, we examined the in situ localization of the
HP1 isoforms as well as H3K9Me3 by immunoﬂuores-
cence staining during myogenic diﬀerentiation. Pericentric
heterochromatin organized in chromocenters was
highlighted by counterstaining with the DNA dye
40,6-diamidino-2-phenylindole (DAPI). We found that
the level of association of HP1 with pericentric hetero-
chromatin diﬀered between isoforms and changed during
diﬀerentiation. While HP1a protein could be found
accumulated at pericentric heterochromatin in most of
the MBs (89%; Supplementary Figure 1), HP1b did not
show such an accumulation (data not shown) and HP1g
showed only a weak heterochromatin accumulation in
about half of the MBs (61%; Figure 2). This weak
accumulation was not due to the absence of H3K9Me3,
since chromocenters of all MBs stained clearly positive for
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Figure 4. MeCP2 interacts via its N-terminal domain with the CSD domain of HP1. Schematic representation of the fusion proteins. Numbers
represent amino acid coordinates. HEK293-EBNA cells were transfected with the plasmids indicated. Immunoprecipitations were done using either
anti-mRFP or anti-GFP antibody. Input (I) and bound (B) fractions were loaded in the percentages mentioned and analyzed by western blotting
using anti-GFP or anti-HP1g (shown here is the endogenous HP1g).
Nucleic Acids Research, 2007, Vol. 35, No. 16 5405this histone modiﬁcation (Supplementary Figure 2) and is
consistent with earlier reports showing HP1g mostly
excluded from constitutive heterochromatin (25). We can
also rule out epitope masking (26), as in the same
population of MBs, there were cells where HP1g staining
was detected at chromocenters (Figure 2A magniﬁed
nucleus). The fraction of MT nuclei with HP1a and g
accumulated at heterochromatin increased to 100 and
90%, respectively (Supplementary Figure 1 and Figure 2).
In contrast, upon diﬀerentiation there was no major
change in the distribution of HP1b (data not shown) even
though there was an increase in the level of its binding site
H3K9Me3 (Figure 1). We reasoned therefore, that this
increase in heterochromatin association could depend on
diﬀerentiation-speciﬁc factors other than the histone
methylation mark per se. Since MeCP2 and other MBDs
are present in a few MB only but increase during
diﬀerentiation and label almost all chromocenters in MT
(16), we tested whether the change in heterochromatin
association of HP1g was correlated to MBD protein.
Indeed we found a clear correlation of HP1 heterochro-
matin association in MB and the presence of either
MeCP2 or MBD1. Almost all MeCP2 or MBD1 positive
MB contained HP1a (100%) and HP1g (95%) at
chromocenters (Figure 2 and Supplementary Figure 1).
Furthermore, 96 and 94% of MB cells ectopically
expressing MeCP2-GFP fusion had HP1g and HP1a
accumulation at pericentric heterochromatin (Figure 2B
and Supplementary Figure 1B). Altogether, these data
showed that the chromocenter association of HP1 with
particular emphasis for HP1g clearly increased upon
myogenic diﬀerentiation and was positively correlated
with the presence of MeCP2 and MBD1.
MeCP2 interacts viaits N-terminal domain with
thechromo shadowdomain of HP1
Since the accumulation of HP1at chromocenters corre-
lated with the presence of MBD proteins at these sites, we
tested whether they could physically interact. HEK293-
EBNA cells, which express HP1 proteins, were transfected
with plasmids coding for GFP, GFP-tagged MeCP2 or
GFP-tagged HP1 (Figure 3A). Twelve hours later, cells
were lysed and immunoprecipitations performed with an
anti-GFP-speciﬁc antibody fragment [GFP binder; (23)].
Input and bound fractions were analyzed on western blots
for precipitated GFP-tagged protein (data not shown) and
for co-precipitated endogenous HP1g protein. HP1g did
not bind to GFP alone but was co-precipitated with
MeCP2-GFP (Figure 3B) and the same was true for HP1a
and b (data not shown). Since HP1a, b and g have been
shown to form homodimers (12,13) as well as hetero-
dimers [HP1a-g; (12)], [HP1a-b; (27)], we reproduced this
data as a positive control for our co-immunoprecipitation
conditions. Moreover, the fraction of HP1g bound to
HP1a was comparable with the amount bound to MeCP2
(Figure 3B). Using a mRFP-tagged MeCP2, we
co-immunoprecipitated GFP-tagged HP1a, b and g
(Figure 3C). MeCP2-GFP proteins could likewise immu-
noprecipitate DsRed2-tagged HP1s (Figure 4 and data not
shown) showing that the interaction of HP1 with MeCP2
was independent of the tags. Further, we tested whether
endogenous HP1 and MeCP2 could interact. We per-
formed immunoprecipitations using anti-MeCP2 antibody
on Pmi28 MBs (expressing low level of MeCP2) and MTs
(expressing higher level of MeCP2) (16). Indeed, the rabbit
anti-MeCP2 antibody but not the control rabbit IgG
could co-precipitate HP1g from MT extracts. Finally, to
test whether MeCP2 could directly interact with HP1, we
used GST pull down assays. Recombinant MeCP2
puriﬁed from bacteria was incubated with glutathione
agarose coupled GST or GST-HP1g (Supplementary
Figure 3). While no MeCP2 protein was detected in the
GST-bound fraction, GST-HP1g was able to speciﬁcally
pull down MeCP2. In summary, these results showed that
MeCP2 and HP1 interact in vivo and at a level comparable
to the dimerization of HP1 proteins.
The N terminus of HP1 contains the H3K9Me3-binding
site (5) while the C terminus mediates dimerization of HP1
as well as interaction with other proteins (11,28). To test
which domain would be involved in the interaction with
MeCP2, we co-transfected HEK293-EBNA cells with
plasmids coding for MeCP2-mRFP and with diﬀerent
YFP-tagged deletion constructs of HP1 isoforms coding
either for the CD or the CSD. Co-immunoprecipitation
assays demonstrated that the CSD of HP1s was necessary
and suﬃcient for binding to MeCP2 in vivo (Figure 4 and
data not shown). The CSD of HP1 has previously been
shown to be important for the interaction of HP1 with
other nuclear proteins (11). We then investigated which
domain of MeCP2 binds to HP1 by using a series of
ﬂuorescently tagged deletion constructs of MeCP2. The
results indicate that amino acids 1–55 of MeCP2 are
primarily involved in binding HP1 (Figure 4), though
weaker binding could be detected with other regions of
MeCP2 as well (Supplementary Figure 4). We conclude
that MeCP2 and HP1 interact via the CSD of HP1 and the
N-terminal domain of MeCP2.
The domains of MeCP2 that have been better function-
ally characterized are the MBD, the transcriptional
repressor domain (TRD) and the overlapping Sin3a
co-repressor domain (coRID), all of which are in the
central part of MeCP2 (29). Our data now implicate the
N-terminal region before the MBD in binding to HP1,
suggesting a direct physical link between the factors
translating DNA and histone methylation. On the one
hand, MeCP2 recognizes methyl CpGs and interacts with
DNA methyltransferase 1 (30). On the other hand, HP1
binds to H3K9Me3 and associates with the histone H3K9
methyltransferase [Suv39h1; (31)]. Our data showing that
HP1 and MeCP2 interact with each other interconnects
these two major epigenetic pathways. Most recently, HP1
was also reported to interact with Dnmt1 (32). It is
noteworthy that another MBD protein, MBD1 has been
reported to interact with HP1a via the MBD (33). Since
other MBDs (Figure 2 and Supplementary Figure 1) were
also able to enhance the accumulation of HP1at hetero-
chromatin, any single MBD knockout would not be
expected to disrupt it. In line with this, we have previously
shown that other MBDs have overlapping functions and
knockout of MeCP2 alone did not aﬀect heterochromatin
reorganization during myogenic diﬀerentiation (16).
5406 Nucleic Acids Research, 2007, Vol. 35, No. 16Signiﬁcantly, we found that the heterochromatin associa-
tion of HP1g increased during diﬀerentiation and that this
was correlated with either MeCP2 or MBD1 presence. The
diﬀerentiation-speciﬁc increase of the MBD proteins could
enhance HP1g binding to constitutive heterochromatin,
which would then recruit histone H3K9 methyltrans-
ferases leading to higher levels of H3K9 methylation. In
Suv39h1/2 double knockout cells where H3K9 methyla-
tion at chromocenters is abrogated, MeCP2 still induced
clustering (16), indicating that its interaction with HP1 is
not required for its function in large-scale chromatin
organization. We further propose that the multiple
interactions of these factors with chromatin and with
each other generate subnuclear silencing compartments,
which stabilize the diﬀerentiated phenotype by reducing
transcriptional noise. Individually these interactions are
transient but their cumulative eﬀect at heterochromatin
increases the local concentration of repressing factors and
thereby the eﬃciency of gene silencing.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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